analyzeportfolio
Nasdaq · Industrials

Hawkins Inc. (HWKN)

As-reported financials and SEC filings for Hawkins Inc. The latest annual period is FY2026. The latest reported quarter is Q1 FY2027. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About Hawkins Inc.

Hawkins Inc formulates, manufactures, distributes, and blends products for water treatment, food and health sciences, and industrial solutions customers. Its Water Treatment segment provides chemicals, filtration media, equipment, and services primarily to municipal, industrial, and agricultural water systems. The Food and Health Sciences segment supplies ingredients and formulation solutions to manufacturers in nutrition, food, pharmaceutical, and agricultural markets, while the Industrial Solutions segment offers industrial chemicals and related services to various industries including manufacturing and chemical processing.

Snapshot

Revenue
$1.08B
Revenue growth (YoY)
11.2%
Net income
$81.5M
Diluted EPS
$3.91
Gross margin
22.6%
Operating margin
11.2%
Net margin
7.5%
FCF margin
7.9%
ROE
15.3%
net income / fiscal-year-end equity
P/E
33.7×
trailing when available, otherwise FY EPS
Market cap
$2.71B
Long-term debt / equity
0.46×
non-current term debt only

Fundamentals are from SEC filings for FY2026, the latest annual period (ended March 29, 2026). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.

What changed at Hawkins

  • Revenue grew 11.2% to $1.1B in FY2026, faster than the 6.0% the year before.
  • Operating margin is 11.2% in FY2026, +2.0 pp against 9.2% in FY2022.
  • Most recent quarter Q1 FY2027: revenue $316M, up 7.6% from Q1 FY2026.
  • Free cash flow was $86M in FY2026, 7.9% of revenue.
  • Net income fell 3.3% to $82M in FY2026.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Hawkins’s fundamentals sit among the 668 Industrials companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

Gross margin22.6%
36th percentile of 455
Operating margin11.2%
69th percentile of 598
Net margin7.5%
67th percentile of 630
FCF margin7.9%
63rd percentile of 546
Revenue growth (YoY)+11.2%
68th percentile of 652
ROE15.3%
72nd percentile of 590
P/E33.7×
73rd percentile of 406
Long-term debt / equity0.46×
46th percentile of 403
Short interest7.52d
90th percentile of 661

2 reported insider purchases (code P) totaling $261,576 in the last 90 days. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →

Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Institutional ownership

Held by 2 of the superinvestors we track (plus 3 quant / multi-strat books), based on each investor’s most recent 13F; periods vary by investor (newest: Q2 2026).

Conviction investors
2
+3 quant / multi-strat
Initiated / added
3
2 new, 1 added
Reduced / exited
4
2 trimmed, 2 exited
Combined position
$21.1M
reported long value
InvestorAs ofPosition valueSharesChange
Giverny CapitalQ2 2026$13.5M95.0KNew
Renaissance TechnologiesquantQ2 2026$4.8M33.7KNew
AQR Capital ManagementquantQ2 2026$1.6M11.2KAdded
Gotham Asset ManagementQ2 2026$688,4754.8KReduced
Millennium ManagementquantQ2 2026$500,7603.5KReduced

No longer held by: Citadel Advisors (as of Q2 2026), Two Sigma Investments (as of Q2 2026)

From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.

Recent insider activity

Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4. Multiple insiders have bought recently (a cluster buy).

Buys (90d)
2
2 insiders
Bought (90d)
$262K
code P value
Sells (90d)
0
—
Reported activity
Cluster buy
≥2 insiders buying
Trade dateInsiderTypeSharesPriceValue
2026-08-27
filed 2026-08-31
Jeffrey P. OldenkampEXECUTIVE VP AND CFOBuy1.3K$119.00$154K
2026-08-25
filed 2026-08-27
Douglas A. LangeVP - WATER TREATMENT GROUPBuy910$118.75$108K

Reported non-derivative purchases and sales (codes P/S), which may be open-market or private. Excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
1.3M
settled 2026-09-30
Change vs prior
-1.6%
vs previous settlement
Days to cover
7.52
at avg daily volume
Avg daily volume
173.4K
FINRA reported
SettlementShares shortChangeDays to cover
2026-09-301.3M-1.6%7.52
2026-09-151.3M+6.3%6.42
2026-08-311.2M-6.5%9.20
2026-08-141.3M+27.0%10.91
2026-07-311.0M-6.6%5.48
2026-07-151.1M+5.3%6.52
2026-06-301.1M+1.6%4.73
2026-06-151.1M-21.4%9.87

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2026FY2025FY2024FY2023FY2022
Revenue$1.08B$974.4M$919.2M$935.1M$774.5M
Gross profit
Operating income$121.3M$119.2M$104.0M$88.2M$71.2M
Net income$81.5M$84.3M$75.4M$60.0M$51.5M
Diluted EPS$3.91$4.03$3.59$2.86$2.44

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (tap or hover a figure to see how it was calculated or what was filed). Full details: where the numbers come from.

Balance sheet (as reported)

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (tap or hover a figure to see how it was calculated or what was filed). Full details: where the numbers come from.

Cash flow (as reported)

 FY2026FY2025FY2024FY2023FY2022
Operating cash flow$144.3M$111.1M$159.5M$77.4M$42.8M
Capital expenditure$58.2M$41.1M$40.2M$48.3M$28.5M
Free cash flow

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (tap or hover a figure to see how it was calculated or what was filed). Full details: where the numbers come from.

Quarterly trend

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q1 FY2027$315.7M7.6%$28.3M$1.35
Q4 FY20268.4%
Q3 FY2026$244.1M7.9%$14.3M$0.69
Q2 FY2026$280.4M13.5%$22.6M$1.08
Q1 FY2026$293.3M14.6%$29.2M$1.40
Q4 FY202510.0%
Q3 FY2025$226.2M8.5%$15.0M$0.72
Q2 FY2025$247.0M4.4%$24.1M$1.16

Latest 8 quarters, from company XBRL filings on SEC EDGAR. A dotted underline marks a fourth-quarter figure we calculated from the full year and the first nine months. Revenue YoY is our calculation too: each quarter against the same quarter a year earlier.

Company facts

ExchangeNasdaq
SectorIndustrials
SIC industryWholesale-Chemicals & Allied Products
Latest annual periodFY2026 (ended March 29, 2026)
Latest reported quarterQ1 FY2027 (ended June 28, 2026)
Oldest indexed filing2001
SEC CIK46250

Selected SEC filings

10-K2026-05-13
View on EDGAR →
10-Q2026-07-29
View on EDGAR →
10-Q2026-01-28
View on EDGAR →
10-Q2025-10-29
View on EDGAR →
8-K2026-08-14
View on EDGAR →
8-K2026-08-03
View on EDGAR →
8-K2026-07-29
View on EDGAR →
8-K2026-05-19
View on EDGAR →

Largest Industrials peers

All Industrials companies →

Monitor HWKN

Get an alert when Hawkins files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor HWKN free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.